CDC recommends Pfizer maternal RSV vaccine to protect infants, paving way for fall availability

The CDC specifically recommended that expectant mothers 32 to 36 weeks into their pregnancy receive the shot, Pfizer's Abrysvo, from September through January. Read this story at , ,

Related Articles

Latest in News

More from CNBC | Business Biotechnology Biotech and Pharmaceuticals Pharmaceuticals Health care industry Pfizer Inc Science Social issues Sanofi SA AstraZeneca PLC Breaking news Respiratory syncytial virus Immunizations Centers for Disease Control and Prevention FDA United States business news cnbc Articles US: News Companies Business News Health & Science source:tagname:CNBC US Source